Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations
- PMID: 10896321
- DOI: 10.1023/a:1008189724803
Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations
Abstract
A series of 5-(arylthio)-2,4-diaminoquinazolines are known as selective inhibitors of dihydrofolate reductase (DHFR) from Candida albicans. We have performed docking and molecular dynamics simulations of these inhibitors with C. albicans and human DHFR to understand the basis for selectivity of these agents. Study was performed on a selected set of 10 compounds with variation in structure and activity. Molecular dynamics simulations were performed at 300 K for 45 ps with equilibration for 10 ps. Trajectory data was analyzed on the basis of hydrogen bond interactions, energy of binding and conformational energy difference. The results indicate that hydrogen bonds formed between the compound and the active site residues are responsible for inhibition and higher potency. The selectivity index, i.e the ratio of I50 against human DHFR to I50 against fungal DHFR, is mainly determined by the conformation adapted by the compounds within the active site of two enzymes. Since the human DHFR active site is rigid, the compound is trapped in a higher energy conformation. This energy difference between the two conformations deltaE mainly governs the selectivity against fungal DHFR. The information generated from this analysis of potency and selectivity should be useful for further work in the area of antifungal research.
Similar articles
-
Selective inhibitors of Candida albicans dihydrofolate reductase: activity and selectivity of 5-(arylthio)-2,4-diaminoquinazolines.J Med Chem. 1995 Sep 1;38(18):3608-16. doi: 10.1021/jm00018a021. J Med Chem. 1995. PMID: 7658448
-
Crystal structures of Candida albicans dihydrofolate reductase bound to propargyl-linked antifolates reveal the flexibility of active site loop residues critical for ligand potency and selectivity.Chem Biol Drug Des. 2011 Oct;78(4):505-12. doi: 10.1111/j.1747-0285.2011.01169.x. Epub 2011 Jul 29. Chem Biol Drug Des. 2011. PMID: 21726415 Free PMC article.
-
In vitro biological activity and structural analysis of 2,4-diamino-5-(2'-arylpropargyl)pyrimidine inhibitors of Candida albicans.Bioorg Med Chem. 2009 Jul 15;17(14):4866-72. doi: 10.1016/j.bmc.2009.06.021. Epub 2009 Jun 17. Bioorg Med Chem. 2009. PMID: 19560363 Free PMC article.
-
DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents.Molecules. 2019 Mar 22;24(6):1140. doi: 10.3390/molecules24061140. Molecules. 2019. PMID: 30909399 Free PMC article. Review.
-
Dihydrofolate reductase inhibitors: patent landscape and phases of clinical development (2001-2021).Expert Opin Ther Pat. 2022 Oct;32(10):1079-1095. doi: 10.1080/13543776.2022.2130752. Epub 2022 Oct 7. Expert Opin Ther Pat. 2022. PMID: 36189616 Review.
Cited by
-
Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs.Med Res Rev. 2019 Mar;39(2):684-705. doi: 10.1002/med.21538. Epub 2018 Sep 7. Med Res Rev. 2019. PMID: 30192413 Free PMC article. Review.
-
3D-QSAR and molecular modeling of HIV-1 integrase inhibitors.J Comput Aided Mol Des. 2002 Mar;16(3):181-200. doi: 10.1023/a:1020137802155. J Comput Aided Mol Des. 2002. PMID: 12363217
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources